BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26109429)

  • 21. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.
    Wu H; Zhang XY; Hu Z; Hou Q; Zhang H; Li Y; Li S; Yue J; Jiang Z; Weissman SM; Pan X; Ju BG; Wu S
    Oncogene; 2017 May; 36(20):2857-2867. PubMed ID: 27941887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
    Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
    Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
    Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
    Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of novel low passage primary and metastatic colorectal cancer cell lines.
    Boot A; van Eendenburg J; Crobach S; Ruano D; Speetjens F; Calame J; Oosting J; Morreau H; van Wezel T
    Oncotarget; 2016 Mar; 7(12):14499-509. PubMed ID: 26894854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell exome sequencing reveals multiple subclones in metastatic colorectal carcinoma.
    Tang J; Tu K; Lu K; Zhang J; Luo K; Jin H; Wang L; Yang L; Xiao W; Zhang Q; Liu X; Ge XY; Li G; Zhou Z; Xie D
    Genome Med; 2021 Sep; 13(1):148. PubMed ID: 34507604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
    Bruin SC; de Ronde JJ; Wiering B; Braaf LM; de Wilt JH; Vincent AD; van Velthuysen ML; Ruers TJ; Wessels LF; van't Veer LJ
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S560-9. PubMed ID: 23783809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing of contralateral breast cancer identifies metastatic disease.
    Klevebring D; Lindberg J; Rockberg J; Hilliges C; Hall P; Sandberg M; Czene K
    Breast Cancer Res Treat; 2015 Jun; 151(2):319-24. PubMed ID: 25922084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for nonresectable liver metastases from colorectal cancer.
    Hagness M; Foss A; Line PD; Scholz T; Jørgensen PF; Fosby B; Boberg KM; Mathisen O; Gladhaug IP; Egge TS; Solberg S; Hausken J; Dueland S
    Ann Surg; 2013 May; 257(5):800-6. PubMed ID: 23360920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TP53 mutation is enriched in colorectal cancer liver metastasis in the context of polyclonal seeding.
    Sun W; Sun Q; Zhong A; Lyne AM; Huang D; Han F; Lai M; Zhang H
    Pathol Res Pract; 2022 Aug; 236():153958. PubMed ID: 35679752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas.
    Miyaki M; Iijima T; Yasuno M; Kita Y; Hishima T; Kuroki T; Mori T
    Oncogene; 2002 Sep; 21(43):6689-93. PubMed ID: 12242668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic evolution and diverse models of systemic metastases in colorectal cancer.
    Chen HN; Shu Y; Liao F; Liao X; Zhang H; Qin Y; Wang Z; Luo M; Liu Q; Xue Z; Cao M; Zhang S; Zhang WH; Hou Q; Xia X; Luo H; Zhang Y; Yang L; Hu JK; Fu X; Liu B; Hu H; Huang C; Peng Y; Cheng W; Dai L; Yang L; Zhang W; Dong B; Li Y; Wei Y; Xu H; Zhou ZG
    Gut; 2022 Feb; 71(2):322-332. PubMed ID: 33632712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
    Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
    PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis.
    Zhang L; Kim S; Jia G; Buhmeida A; Dallol A; Wright WE; Fornace AJ; Al-Qahtani M; Shay JW
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S8. PubMed ID: 25923178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.
    Zheng P; Ren L; Feng Q; Zhu D; Chang W; He G; Ji M; Jian M; Lin Q; Yi T; Wei Y; Xu J
    Cancer Manag Res; 2018; 10():2871-2881. PubMed ID: 30214282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
    Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
    Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
    Molleví DG; Serrano T; Ginestà MM; Valls J; Torras J; Navarro M; Ramos E; Germà JR; Jaurrieta E; Moreno V; Figueras J; Capellà G; Villanueva A
    Carcinogenesis; 2007 Jun; 28(6):1241-6. PubMed ID: 17259658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.